Anagliptin ameliorates high glucose- induced endothelial dysfunction via suppression of NLRP3 inflammasome activation mediated by SIRT1 | |
Jiang, Tiechao; Jiang, Dongli; Zhang, Lirong; Ding, Mei; Zhou, Hui | |
刊名 | MOLECULAR IMMUNOLOGY |
2019 | |
卷号 | 107 |
关键词 | Type 2 diabetes mellitus Anagliptin NLRP3 infammasome SIRT1 Endothelial dysfunciton |
ISSN号 | 0161-5890 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3512077 |
专题 | 吉林大学白求恩第三医院 |
推荐引用方式 GB/T 7714 | Jiang, Tiechao,Jiang, Dongli,Zhang, Lirong,et al. Anagliptin ameliorates high glucose- induced endothelial dysfunction via suppression of NLRP3 inflammasome activation mediated by SIRT1[J]. MOLECULAR IMMUNOLOGY,2019,107. |
APA | Jiang, Tiechao,Jiang, Dongli,Zhang, Lirong,Ding, Mei,&Zhou, Hui.(2019).Anagliptin ameliorates high glucose- induced endothelial dysfunction via suppression of NLRP3 inflammasome activation mediated by SIRT1.MOLECULAR IMMUNOLOGY,107. |
MLA | Jiang, Tiechao,et al."Anagliptin ameliorates high glucose- induced endothelial dysfunction via suppression of NLRP3 inflammasome activation mediated by SIRT1".MOLECULAR IMMUNOLOGY 107(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论